Coronary Circulation Clinical Trial
— SUGO-KOOfficial title:
Effects of Suggestive Components of Therapeutical Interventions on the Diameter of Coronary Arteries
Verified date | June 2009 |
Source | Technische Universität München |
Contact | n/a |
Is FDA regulated | No |
Health authority | Germany: Ethics Commission |
Study type | Interventional |
The aim of this randomized controlled pilot study was to answer the following questions:
1. Is it possible to affect the diameter of coronary arteries through a placebo injection,
which is administered intracoronarily together with a standardized verbal suggestion of
coronary vasodilation?
2. Is it possible to affect the diameter of coronary arteries through a pharmacologically
underdosed nitroglycerine injection, which is administered intracoronarily together
with a standardized verbal suggestion of coronary vasodilation?
Status | Completed |
Enrollment | 60 |
Est. completion date | August 2008 |
Est. primary completion date | August 2008 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 80 Years |
Eligibility |
Inclusion Criteria: - medical indication for heart catheterization - written informed consent Exclusion Criteria: - acute myocardial infarction - acute elevation of cardiac enzymes - regular intake of drugs containing nitroglycerin - intolerance of nitroglycerin - hypotension - renal insufficiency - diabetes mellitus - hyperthyroidism - pregnancy - acute psychiatric disease - cognitive impairment - prinzmetal's angina |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science
Country | Name | City | State |
---|---|---|---|
Germany | Department of Psychosomatic Medicine, Technische Universität München | Munich |
Lead Sponsor | Collaborator |
---|---|
Technische Universität München | German Heart Center, Ludwig-Maximilians - University of Munich |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Stenosis Diameter (Quantitative Coronary Analysis) | 60 sec after intervention | No | |
Secondary | Heart rate | immediately before and after intervention | No | |
Secondary | Systolic blood pressure | immediately before and after intervention | No | |
Secondary | Diastolic blood pressure | immediately before and after intervention | No | |
Secondary | Chest Pain | immediately before and after intervention | No | |
Secondary | Subjective distress | immediately before and after intervention | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03193294 -
CORonary MICrovascular Angina (CorMicA)
|
N/A | |
Recruiting |
NCT03033810 -
FFR Versus iFR in Assessment of Hemodynamic Lesion Significance
|
N/A | |
Recruiting |
NCT04575207 -
The Flash FFR Ⅱ Study
|
N/A | |
Active, not recruiting |
NCT03656848 -
The FAVOR III China Study
|
N/A | |
Completed |
NCT03067844 -
Vascular Effects of Alirocumab in Acute MI-Patients
|
Phase 3 |